Ken Griffin Elanco Animal Health Inc Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 206,300 shares of ELAN stock, worth $2.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

206,300

Previous 186,100 10.85%

Holding current value

$2.59 Million

Previous $3.03 Million 1.75%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$12.93 - $18.45 $9.03 Million - $12.9 Million	698,005 Added 5.78%	12,779,733 $184 Million
Q1 2024 May 15, 2024	BUY	$14.37 - $16.46 $26.7 Million - $30.6 Million	1,859,620 Added 18.19%	12,081,728 $197 Million
Q4 2023 Feb 14, 2024	SELL	$8.6 - $14.94 $30.9 Million - $53.7 Million	-3,593,495 Reduced 26.01%	10,222,108 $152 Million
Q3 2023 Nov 14, 2023	BUY	$9.81 - $12.62 $5.49 Million - $7.06 Million	559,193 Added 4.22%	13,815,603 $155 Million
Q2 2023 Aug 14, 2023	BUY	$8.08 - $10.37 $77.6 Million - $99.6 Million	9,602,677 Added 262.82%	13,256,410 $133 Million
Q1 2023 May 15, 2023	BUY	$8.79 - $14.58 $10.5 Million - $17.4 Million	1,191,064 Added 48.36%	3,653,733 $34.3 Million
Q4 2022 Feb 14, 2023	SELL	$11.49 - $13.65 $95.6 Million - $114 Million	-8,322,076 Reduced 77.17%	2,462,669 $30.1 Million
Q3 2022 Nov 14, 2022	BUY	$12.41 - $32.42 $127 Million - $332 Million	10,239,562 Added 1878.19%	10,784,745 $134 Million
Q2 2022 Aug 15, 2022	SELL	$19.63 - $26.62 $984,091 - $1.33 Million	-50,132 Reduced 8.42%	545,183 $10.7 Million
Q1 2022 May 16, 2022	SELL	$24.65 - $29.0 $15 Million - $17.6 Million	-607,141 Reduced 50.49%	595,315 $15.5 Million
Q4 2021 Feb 14, 2022	SELL	$27.74 - $34.09 $5.23 Million - $6.43 Million	-188,527 Reduced 13.55%	1,202,456 $34.1 Million
Q3 2021 Nov 15, 2021	SELL	$29.2 - $36.72 $1.95 Million - $2.45 Million	-66,675 Reduced 4.57%	1,390,983 $44.4 Million
Q2 2021 Aug 16, 2021	SELL	$28.76 - $35.98 $5.29 Million - $6.61 Million	-183,818 Reduced 11.2%	1,457,658 $50.6 Million
Q1 2021 May 17, 2021	SELL	$27.85 - $34.49 $27.5 Million - $34 Million	-986,955 Reduced 37.55%	1,641,476 $48.3 Million
Q4 2020 Feb 16, 2021	BUY	$27.53 - $33.79 $69.1 Million - $84.8 Million	2,508,431 Added 2090.36%	2,628,431 $80.6 Million
Q3 2020 Nov 16, 2020	BUY	$21.1 - $29.13 $129,321 - $178,537	6,129 Added 5.38%	120,000 $3.35 Million
Q2 2020 Aug 14, 2020	SELL	$18.94 - $24.93 $6.33 Million - $8.33 Million	-334,263 Reduced 74.59%	113,871 $2.44 Million
Q1 2020 May 15, 2020	SELL	$16.68 - $32.25 $3.26 Million - $6.3 Million	-195,206 Reduced 30.34%	448,134 $10 Million
Q4 2019 Feb 14, 2020	SELL	$25.29 - $29.45 $5.08 Million - $5.91 Million	-200,814 Reduced 23.79%	643,340 $18.9 Million
Q3 2019 Nov 14, 2019	SELL	$25.62 - $34.96 $34.5 Million - $47.1 Million	-1,346,529 Reduced 61.47%	844,154 $22.4 Million
Q2 2019 Aug 14, 2019	SELL	$31.11 - $34.79 $176 Million - $196 Million	-5,641,514 Reduced 72.03%	2,190,683 $74 Million
Q1 2019 May 15, 2019	BUY	$29.0 - $32.83 $202 Million - $229 Million	6,970,355 Added 808.77%	7,832,197 $0
Q3 2018 Nov 13, 2018	BUY	$34.1 - $36.19 $29.4 Million - $31.2 Million	861,842 New	861,842 $0

Others Institutions Holding ELAN

# of Institutions

439

Shares Held

479M

Call Options Held

3.1M

Put Options Held

1.26M

View Full List

About Elanco Animal Health Inc

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $5.95B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

More about ELAN

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account